Reflections from Tokyo: Prospection’s Pharma Executive Roundtable on AI and Generative AI

Bruce Goodwin, former President of Janssen Japan and Managing Director of Janssen ANZ as well as Prospection Board member, shares his reflections and key takeaways from moderating Prospection’s Pharma Executive Roundtable on AI and Generative AI in Tokyo. Get Bruce’s take on how these technologies are transforming drug commercialization and the challenges and opportunities they present.

Published Research: Otsuka sheds light on Myelodysplasia Treatment in Australia with Patient-centric Intelligence

A recent study in eJHaem led by Anoop Enjeti, MD, PhD, in collaboration with Otsuka and Prospection, highlights the importance of treatment adherence and the need for more treatment options for Myelodysplastic Syndromes (MDS). It also showcases the critical role patient-centric intelligence can play in deepening understanding of treatment performance and patient behaviors, on the path to improving patient outcomes.

Reimagining Brand Management With Patient-centric Intelligence

Patient-centric Intelligence (PCI) is transforming the way pharmas manage their brands. It helps companies quickly get to actionable insights informed by the patient journey, and insights centered around patients inevitably lead to better outcomes, for pharmas as well as patients.